DNAswitch is a biotech company committed to develop gene therapy treatments tailored at people with Huntington’s disease. Located in Padua, Italy, it was founded by Prof. Graziano Martello and Dr. Anna Maria Gambetta starting from April 2024. This budding spin-off of the University of Padua has backing from Fondazione Golinelli Partners that helps it grow the future of genetic medicine.
Company Details
- Founded
- -
- Address
- Padova, Padova 35131, It
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Show more similar pages.
- HQ
- Padova, Padova
Dnaswitch Questions
Dnaswitch's LinkedIn profile is https://it.linkedin.com/company/dnaswitch
Dnaswitch's industry is
Biotechnology Research
Dnaswitch's top competitors are
Ciefas,
Laboratorio Paravicini,
Swee-Thy,
Baze,
Polirna,
G-Factor, Incubator-Accelerator Of Fondazione Golinelli,
Paris Basket Fauteuil,
Nuhpro,
Gsk,
Dynamic42 Gmbh.
Dnaswitch's categories are Biotechnology Research
Dnaswitch's founding year is 2024
